Loren Hulse

Loren delivers sophisticated counsel in the creation, management, and protection of domestic and foreign patent and trademark portfolios to companies disrupting the life sciences, chemical, pharmaceutical, biotech, manufacturing, and medical device industries.

From his experience working as former in-house intellectual property counsel, Loren understands the business imperative to create robust protection strategies while managing patent and trademark portfolios that align with corporate priorities.

As a practitioner, Loren has developed, managed, and protected both large and small domestic and foreign patent and trademark portfolios. His wide-ranging biotech and pharmaceutical experience includes advising clients how to protect small molecule and peptide drugs, methods of treatment, genetic constructs and therapies, nucleotide analogs, and RNA-related drug technologies. He has also counseled clients developing medical devices such as optically-guided feeding tubes, injectors, diagnostic kits, catheters, and cardiac assist devices. In the chemical arena, Loren’s experience includes assisting clients to protect solid oxide fuel cell technologies, ionically-conductive membrane applications, and syngas production techniques.

Member, American Intellectual Property Law Association